DSLT has safety and efficacy similar to SLT and offers several advantages to both patients and physicians that may increase adoption of this important technology in U.S. and global populations, especially in underserved communities lacking specialized glaucoma care. The noncontact and “direct” approach allow for treatment without the need for specialized gonioscopic techniques while offering a more patient-friendly experience and clinical efficiencies for physicians and clinics.